The economic burden of adults with major depressive disorder in the United States (2005 and 2010).
about
Is increased antidepressant exposure a contributory factor to the obesity pandemic?Nine traditional Chinese herbal formulas for the treatment of depression: an ethnopharmacology, phytochemistry, and pharmacology reviewThe attributable annual health costs of U.S. occupational lead poisoningWorking hours and the onset of depressive disorder: a systematic review and meta-analysis.Cognitive dysfunction and work productivity in major depressive disorder.Brain arousal regulation as response predictor for antidepressant therapy in major depression.Molecular, Functional, and Structural Imaging of Major Depressive Disorder.Using a smartphone app to reduce cognitive vulnerability and mild depressive symptoms: Study protocol of an exploratory randomized controlled trial.Accelerated aging of the putamen in patients with major depressive disorder.Experimental medication treatment approaches for depression.Lifetime Economic Burden of Rape Among U.S. Adults.Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study.Treatment patterns, healthcare resource utilization, and costs following first-line antidepressant treatment in major depressive disorder: a retrospective US claims database analysis.Mechanism Underlying Acupuncture-Ameliorated Depressive Behaviors by Enhancing Glial Glutamate Transporter in Chronic Unpredictable Mild Stress (CUMS) RatsQuality indicators for care of depression in primary care settings: a systematic review.Target-D: a stratified individually randomized controlled trial of the diamond clinical prediction tool to triage and target treatment for depressive symptoms in general practice: study protocol for a randomized controlled trial.Emerging treatment mechanisms for depression: focus on glutamate and synaptic plasticity.Beyond serotonin: newer antidepressants in the future.Editorial overview: The assessment, etiology, and treatment of unipolar depressionJapan Unified Protocol Clinical Trial for Depressive and Anxiety Disorders (JUNP study): study protocol for a randomized controlled trial.The economic burden of mental disorders in China, 2005-2013: implications for health policy.The MD Blues: Under-Recognized Depression and Anxiety in Medical TraineesEffects of a Polymorphism of the Neuronal Amino Acid Transporter SLC6A15 Gene on Structural Integrity of White Matter Tracts in Major Depressive Disorder.Anhedonia and the brain reward circuitry in depression.The relationship between mobile phone location sensor data and depressive symptom severity.Vicarious social defeat stress: Bridging the gap between physical and emotional stress.Transcranial magnetic stimulation potentiates glutamatergic neurotransmission in depressed adolescents.Depression as a systemic syndrome: mapping the feedback loops of major depressive disorder.The association of an inability to form and maintain close relationships due to a medical condition with anxiety and depressive disordersMoodHacker Mobile Web App With Email for Adults to Self-Manage Mild-to-Moderate Depression: Randomized Controlled TrialImpact of diagnosed depression on healthcare costs in adults with and without diabetes: United States, 2004-2011.Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor.Trends in Costs of Depression in Adults with Diabetes in the United States: Medical Expenditure Panel Survey, 2004-2011.Duality of Antidepressants and Neuroprotectants.Circuit-wide Transcriptional Profiling Reveals Brain Region-Specific Gene Networks Regulating Depression Susceptibility.Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 1. Disease Burden and Principles of Care.Clinical application of DEX/CRH test and multi-channel NIRS in patients with depression.Pharmaceutical Innovation in the Treatment of Schizophrenia and Mental Disorders Compared with Other Diseases.Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment.The Relationship Between Physical Activity and Depressive Symptoms in Healthy Older Women.
P2860
Q26765430-2246636A-5457-4470-8FDC-C68E40E117D8Q28067988-B34777B8-CDBD-42B8-80F5-7B59660EC32DQ28386648-443B9E09-7AD9-4E5B-BB80-30942215173EQ30241176-C7EEB6EF-AEBE-4102-B26E-AD33B5B95EB0Q30249792-54D5346F-C758-4BD8-AA70-9EBA0AB21795Q30842926-1EEDF4AD-5CB7-466A-A17A-0545C4E41FAAQ31090058-582A5FB7-31D8-4398-83F1-8A614C03BEE9Q33452067-645703ED-055E-4C60-A323-3F77744C73A9Q33599288-923B5228-2568-45A3-B858-08101A5DC5FBQ33635577-9AA4D2F5-BDCF-494A-8CF0-9624C17EF7F2Q33710207-BC36A266-B681-430B-B066-33E4EC61F25EQ33797383-50B4C4BF-5E0A-4431-9396-99587131B391Q33814867-96040762-7BD1-4CD8-AF03-88CD12519822Q33858984-DC801C9D-93A3-464F-A61C-074EDAA550D0Q33869020-3995B4E5-0228-487E-9B78-74091ADF1341Q33921898-07081711-2518-4A98-94BF-E305309048D0Q34512818-4D8FC6A7-46F7-42F5-9043-6B88139B4EE5Q34557706-DA48333A-97C1-4418-8F19-F0C3FE3E7E1FQ35926573-6CC61587-5F96-450F-AAC3-B9B4CA52B2D2Q35961390-ED23678B-42E5-4D12-81FC-7F51A048A96FQ36015076-ABC29A21-6602-4E95-BBC6-D68F29DD60E9Q36048486-5A2F48D3-54CA-485C-8DF7-4C2F3B8AA082Q36159230-865546F7-1815-40FA-A205-66972DD60195Q36224442-3897AAE2-20DA-4768-ACBE-93124C7A0A38Q36323394-4A5E4954-6047-4043-A4F6-D321547C5251Q36405502-96E1EB28-3E24-45E6-93B2-9380CD63C9EDQ36474017-EAA3E519-FA6A-4061-AFC0-FC130EF8C5F1Q36532479-C4387966-3431-4A40-B997-1FCE6160C608Q36553546-F1592B63-C750-4F44-953F-3910655427E7Q36564775-203F9F61-9288-4279-8C52-E593E56DBEBCQ36656005-8A352757-89BD-4700-B904-4D17F29FDF1EQ36774320-4F59287C-0555-43C2-BB6E-C96B33A23B33Q36910146-1E480E45-9C91-499F-918F-F9C7DAAB1A22Q36944840-6AC4C607-C716-4B01-9F36-8D8BD1227BFAQ36978291-1841FDB4-D701-4D88-A94B-664BF45966BEQ37197211-B925796C-EC74-48D5-94BB-09C792D621AAQ37224342-12F2CA84-67D1-4945-BB1B-6833F37C8E4CQ37255533-A3B00B5C-EEF3-49F9-AB9B-B5EA19CDC43EQ37310533-BE28838B-9015-4638-86E4-6C5922AB049EQ37429427-C48298EA-2C3E-449F-BA54-3A3D61AF2900
P2860
The economic burden of adults with major depressive disorder in the United States (2005 and 2010).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The economic burden of adults ...... United States (2005 and 2010).
@en
The economic burden of adults with major depressive disorder in the United States
@nl
type
label
The economic burden of adults ...... United States (2005 and 2010).
@en
The economic burden of adults with major depressive disorder in the United States
@nl
prefLabel
The economic burden of adults ...... United States (2005 and 2010).
@en
The economic burden of adults with major depressive disorder in the United States
@nl
P2093
P356
P1476
The economic burden of adults ...... United States (2005 and 2010).
@en
P2093
Andree-Anne Fournier
Crystal T Pike
Paul E Greenberg
Tammy Sisitsky
P304
P356
10.4088/JCP.14M09298
P577
2015-02-01T00:00:00Z